Patient Capital Management’s Alibaba BABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,114
Closed -$14.7M 41
2025
Q4
$14.7M Sell
100,114
-389,563
-80% -$63.4M 0.57% 34
2025
Q3
$87.5M Sell
489,677
-9,433
-2% -$1.24M 3.5% 11
2025
Q2
$56.6M Sell
499,110
-34,979
-7% -$4.14M 2.55% 20
2025
Q1
$70.6M Sell
534,089
-155,623
-23% -$17.9M 3.63% 11
2024
Q4
$58.5M Buy
689,712
+30,986
+5% +$2.93M 2.7% 20
2024
Q3
$69.9M Sell
658,726
-67,800
-9% -$5.55M 3.43% 10
2024
Q2
$52.3M Buy
726,526
+93,325
+15% +$7.16M 2.78% 16
2024
Q1
$45.8M Buy
633,201
+56,737
+10% +$4.16M 2.23% 22
2023
Q4
$44.7M Sell
576,464
-57,661
-9% -$4.59M 2.37% 18
2023
Q3
$55M Sell
634,125
-36,285
-5% -$3.32M 3.23% 12
2023
Q2
$55.9M Buy
670,410
+583,260
+669% +$51M 3.11% 14
2023
Q1
$8.9M Sell
87,150
-1,225
-1% -$123K 3.97% 5
2022
Q4
$7.78M Sell
88,375
-3,675
-4% -$290K 3.78% 5
2022
Q3
$7.36M Sell
92,050
-32,150
-26% -$3.06M 3.67% 8
2022
Q2
$14.1M Buy
124,200
+21,400
+21% +$2.1M 6.25% 2
2022
Q1
$11.2M Buy
102,800
+26,600
+35% +$3.06M 3.79% 4
2021
Q4
$9.05M Buy
+76,200
New +$11.1M 2.61% 12

Other funds holding BABA

Patient Capital Management's BABA Position: Q1 2026 in Review

Patient Capital Management sold out of Alibaba (BABA) in Q1 2026, closing a stake of 100,114 shares — an estimated $14.7M sold.

Patient Capital Management first reported a position in BABA in Q4 2021 and held it in 17 quarters. The position peaked at $87.5M in Q3 2025. 1,343 funds tracked by Wall St. Rank hold BABA as of Q1 2026.

  • Patient Capital Management reported no remaining Alibaba position as of Q1 2026 after selling out during the quarter.
  • Patient Capital Management sold 100,114 Alibaba shares in Q1 2026, an estimated $14.7M.
  • Patient Capital Management first reported a position in Alibaba in Q4 2021 and held it in 17 quarters.
  • Patient Capital Management's Alibaba position peaked at $87.5M in Q3 2025.
  • 1,343 funds tracked by Wall St. Rank held Alibaba as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.